Mirae Asset Global Investments
ALDX icon

Mirae Asset Global Investments’s Aldeyra Therapeutics ALDX Stock Holding History

Mirae Asset Global Investments’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-32,151
Closed -$215K – 2524
2023
Q3 		$215K Sell
32,151
-17
-0.1% -$126 ﹤0.01% 2268
2023
Q2 		$266K Buy
+32,168
New +$317K ﹤0.01% 2235

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global Investments's ALDX Position: Q4 2023 in Review

Mirae Asset Global Investments sold out of Aldeyra Therapeutics (ALDX) in Q4 2023, closing a stake of 32,151 shares — an estimated $215K sold.

Mirae Asset Global Investments first reported a position in ALDX in Q2 2023 and held it in 2 quarters. The position peaked at $266K in Q2 2023. 105 funds tracked by Wall St. Rank hold ALDX as of Q4 2023.

  • Mirae Asset Global Investments reported no remaining Aldeyra Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Mirae Asset Global Investments sold 32,151 Aldeyra Therapeutics shares in Q4 2023, an estimated $215K.
  • Mirae Asset Global Investments first reported a position in Aldeyra Therapeutics in Q2 2023 and held it in 2 quarters.
  • Mirae Asset Global Investments's Aldeyra Therapeutics position peaked at $266K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q4 2023.

Based on Mirae Asset Global Investments's 13F filing for Q4 2023, filed 24 Jan 2024.